Cover Image

Medicaid prescription drug reimbursement : why the government pays too much : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, second session, December 7, 2004.

Bibliographic Details
Corporate Author:	United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
Format:	Government Document Book
Language:	English
Published:	Washington : U.S. G.P.O. : 2005.
Subjects:	Medicaid. Prescription pricing > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS59803

Similar Items

Medicaid prescription drug reimbursement : why the government pays too much : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, second session, December 7, 2004.
Published: (2005)

Medicaid prescription drugs : examining options for payment reform : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, June 22, 2005.
Published: (2005)

Medicaid prescription drugs : examining options for payment reform : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, June 22, 2005.
Published: (2005)

Medicaid prescription drugs : examining options for payment reform : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, June 22, 2005.
Published: (2005)

Medicaid prescription drugs : CMS should implement revised federal upper limits and monitor their relationship to retail pharmacy acquisition costs : report to congressional requesters.
Published: (2013)

Medicaid prescription drug pricing : hearing before the Subcommittee on Health for Families and the Uninsured of the Committee on Finance, United States Senate, One Hundred First Congress, second session, on S. 2605 and S. 3029, September 17, 1990.
Published: (1991)

Medicaid prescription drug pricing and policy /
by: Binder, Cliff
Published: (2019)

Medicaid drug rebate program : inadequate oversight raises concerns about rebates paid to states : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives /
by: King, Kathleen
Published: (2005)

Medicaid outpatient prescription drugs : second quarter 2008 federal upper limits for reimbursement compared with average retail pharmacy acquisition costs : [letter to Charles E. Grassley, Ranking Member, Committee on Finance, United States Senate /
by: Dicken, John E.
Published: (2009)

Prescription drug price inflation : are prices rising too fast? : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, December 8, 2009.
Published: (2012)

Problems with Prescription Drug Cards /
Published: (2001)

The politics of the international pricing of prescription drugs /
by: Harrison, Christopher Scott
Published: (2004)

Lowering prescription drug prices : deconstructing the drug supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 9, 2019.
Published: (2021)

Medicaid's Reimbursements to Pharmacies for Prescription Drugs : CBO Paper /
Published: (2004)

Prescription Drug Prices in Canada, Europe, and Japan /
Published: (2001)

The insular areas Medicaid cliff : oversight hearing before the Committee on Natural Resources, U.S. House of Representatives, One Hundred Sixteenth Congress, first session, Thursday, May 23, 2019.
Published: (2019)

States' collection of offset and supplemental Medicaid rebates.
Published: (2014)

State Medicaid drug formularies : cost saving measure or second-class medicine? : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Third Congress, first session, June 9, 1993.
Published: (1995)

Medicaid's reimbursements to pharmacies for prescription drugs.
by: Anderson, Todd
Published: (2004)

Brand-name prescription drug pricing : lack of therapeutically equivalent drugs and limited competition may contribute to extraordinary price increases : report to congressionals requesters.
Published: (2009)

Guide to prescription drug costs /
Published: (1980)

Full committee hearing on Medicaid drug reimbursements : are CMS cuts bad medicine for small businesses and beneficiaries? /
Published: (2007)

Resolution of inquiry directing the Secretary of Health and Human Services to provide certain documentation to the House of Representatives relating to the negotiation of prices for prescription drugs under the Medicare prescription drug program : adverse report together with minority views (to accompany H. Res. 1284).
Published: (2022)

Reauthorization of the Prescription Drug User Fee Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, April 17, 2007.
Published: (2008)

Prescription drugs : prices available through discount cards and from other sources.
by: Dummit, Laura A.
Published: (2001)

A review of the administration's FY2005 health care priorities : hearing before the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, second session, March 10, 2004.
Published: (2004)

Comparison of reimbursement prices for multiple-source prescription drugs in the United States and Canada.
Published: (1991)

The new handbook of prescription drugs: official names, prices, and sources for patient and doctor.
by: Burack, Richard
Published: (1970)

Republican Prescription Drug Legislation (H.R. 4954) Will Not End Drug Price Discrimination /
Published: (2002)

Prescription drug prices : are we getting our money's worth? : a majority staff report of the Special Committee on Aging, United States Senate.
Published: (1989)

Response to Drug Industry Claims on Prescription Drug Price Differences Between the U.S. and Other Countries /
Published: (2002)

Prescription drug pricing : implications for retail pharmacies : statement of Sarah F. Jaggar, Director, Health Services Quality and Public Health, Health, Education, and Human Services Division, before the Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives /
by: Jaggar, Sarah F.
Published: (1996)

Medicare prescription drug discount cards : immediate savings for seniors : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, second session, May 20, 2004.
Published: (2005)

Developments in the prescription drug market : oversight : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fourteenth Congress, second session, February 4, 2016.
Published: (2017)

Prescription Drugs Are More Expensive in Rep. Waxman's Congressional District in California Than in Canada, Europe, and Japan /
Published: (2002)

Prescription Drugs Are More Expensive in the 4th Congressional District in Arkansas Than in Canada, Europe, and Japan /
Published: (2002)

Prescription drug prices : should the federal government regulate them? /
by: Guenther, Gary
Published: (1992)

Examining the actions of drug companies in raising prescription drug prices : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, January 29, 2019.
Published: (2019)

4 ways to help lower your Medicare prescription drug costs.
Published: (2016)

Medicare reimbursements of physician-administered drugs : hearing before the Subcommittee on Health of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Ninth Congress, second session, July 13, 2006.
Published: (2006)